SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.870+2.1%Jan 26 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Spillane who wrote (902)1/16/1999 4:58:00 AM
From: Anthony Wong  Read Replies (1) of 2539
 
Dan, where did you find out about this study? Since Celebrex is not even out in the market until Jan. 21, while Vioxx hasn't yet been approved, I am suspicious that such a study even exists. They can't do comparative studies on drugs that aren't available, or can they? Could this be a rumor floated around by those who have most to lose???? Actually many pharmaceutical companies other than MTC and Merck are developing Cox-2 inhibitors, dead eager to enter this highly lucrative market. A lot of money is at stake.

Regards.

Anthony
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News